Endo Hits Ch. 11 Amid Opioid Suit Crush
Besieged by opioid crisis lawsuits, drugmaker Endo International has filed for Chapter 11 protection in a New York bankruptcy court, saying a deal will cut $6 billion in debt and earmark...To view the full article, register now.
Already a subscriber? Click here to view full article